Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Must Reads In Cardiology

Cardiology for November/December 2015

Cholesterol Treatment Eligibility & Medication Use, Prevalence among US adults examined

Normal-Weight Central Obesity & Mortality, How it compares to BMI-defined obesity

Cardiorespiratory Fitness and Obesity, Identifying men at increased mortality risk

Coffee Consumption and Risk of Mortality, How many cups are too many?

Walnut Ingestion and Diet Quality, Effects on body composition, cardiac risk studied

More must reads

Cardiology for September/October 2015

Screening for High Blood Pressure, USPSTF updates guidelines

Insulin Dose and Cardiovascular Mortality, Does intensive T2D treatment heighten CV risk?

FDA Approves Praxbind as Reversal Agent, Drug reverses effects of dabigatran

Physical Activity and Heart Failure Risk, Examining the dose response relationship

Cardiac Troponin in Patients with ACS, Can hospital admissions be reduced?

More must reads

Cardiology for July/August 2015

Mood Disorders Predispose Youth to Early CVD, AHA scientific statement cites MDD and BD

Prevention of CVD in Adults with Type 2 Diabetes, AHA/ADA provides updated scientific statement

Spicy Foods and Mortality, Population-based study examines links

FDA Approves LDL Cholesterol Drug, PCSK9 inhibitor targets high LDL levels in adults

Abdominal Aortic Aneurysm in Older Adults, Evaluating the long-term outcomes

More must reads

Cardiology for May/June 2015

Reducing the Risk of Heart Failure, AHA’s Life’s Simple 7 guidelines provide a healthy framework

More must reads

Cardiology for March/April 2015

FDA Approves Drug for Chronic Heart Failure , Ivabradine reduces hospitalizations from worsening condition

A Simple Tool for Assessing Physical Activity Levels, One question can improve mortality risk classification

More must reads